Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Orphan grants Kirin Brewery marketing and distribution rights to Busulfex for Asia

Dec. 28, 2000

Bioenvision to codevelop clofarabine for leukemia; mode of action examined at UCSD

Dec. 28, 2000

Novel steroid compounds demonstrate anticancer potential

Dec. 27, 2000

SLIL designs conformationally restricted polyamine analogues for cancer therapy

Dec. 27, 2000

New oncolytic drugs from Schering-Plough act by inhibiting protein farnesyltransferase

Dec. 22, 2000

Recent patent covers new GnRH antagonists prepared by Merck scientists

Dec. 22, 2000

Preclinical trials with decitabine suggest potential in myelodysplastic syndrome, multiple myeloma

Dec. 22, 2000

Potent, selective proteasome compounds derived from belactosin

Dec. 22, 2000

York Medical changes name, reports pipeline progress

Dec. 22, 2000

Protein farnesyltransferase inhibitors useful for cancer therapy patented by BMS

Dec. 21, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...